Tags

Type your tag names separated by a space and hit enter

Deciphering Vaccines for COVID-19: where do we stand today?
Immunopharmacol Immunotoxicol. 2021 Feb; 43(1):8-21.II

Abstract

Pneumonia of unknown etiology was detected in a few patients in Wuhan City, Hubei Province, China. The causative agent was named as the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by the World Health Organization (WHO). The disease caused by this virus was named as a new coronavirus disease: COVID-19. The disease has a global impact affecting more than 200 nations including the USA, India, Brazil, Russia, and Peru are the 5 most severely affected nations. The discovery of the genotype and phenotype of SARS-CoV-2 boosted the global efforts for the development of treatment options and vaccines for the COVID-19. As the transmission of the virus is rapid, to protect the global population, the development of an effective vaccine against the virus is very essential. The current review highlights the various platforms and technologies used globally for the development of the vaccine and also focuses on the current status of the vaccine candidates under development by organizations to combat the global threat of COVID-19 pandemic.

Authors+Show Affiliations

Department of Pharmacology, SVKM's Dr. Bhanuben Nanavati College of Pharmacy, Mumbai, India.Department of Pharmacology, SVKM's Dr. Bhanuben Nanavati College of Pharmacy, Mumbai, India.Department of Pharmacology, SVKM's Dr. Bhanuben Nanavati College of Pharmacy, Mumbai, India.

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

33054486

Citation

Baviskar, Tushar, et al. "Deciphering Vaccines for COVID-19: Where Do We Stand Today?" Immunopharmacology and Immunotoxicology, vol. 43, no. 1, 2021, pp. 8-21.
Baviskar T, Raut D, Bhatt LK. Deciphering Vaccines for COVID-19: where do we stand today? Immunopharmacol Immunotoxicol. 2021;43(1):8-21.
Baviskar, T., Raut, D., & Bhatt, L. K. (2021). Deciphering Vaccines for COVID-19: where do we stand today? Immunopharmacology and Immunotoxicology, 43(1), 8-21. https://doi.org/10.1080/08923973.2020.1837867
Baviskar T, Raut D, Bhatt LK. Deciphering Vaccines for COVID-19: Where Do We Stand Today. Immunopharmacol Immunotoxicol. 2021;43(1):8-21. PubMed PMID: 33054486.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Deciphering Vaccines for COVID-19: where do we stand today? AU - Baviskar,Tushar, AU - Raut,Dezaree, AU - Bhatt,Lokesh Kumar, Y1 - 2020/10/25/ PY - 2020/10/16/pubmed PY - 2021/1/22/medline PY - 2020/10/15/entrez KW - COVID-19 KW - nucleic acid-based vaccine KW - protein-based vaccine KW - vaccine KW - viral vector-based vaccine SP - 8 EP - 21 JF - Immunopharmacology and immunotoxicology JO - Immunopharmacol Immunotoxicol VL - 43 IS - 1 N2 - Pneumonia of unknown etiology was detected in a few patients in Wuhan City, Hubei Province, China. The causative agent was named as the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by the World Health Organization (WHO). The disease caused by this virus was named as a new coronavirus disease: COVID-19. The disease has a global impact affecting more than 200 nations including the USA, India, Brazil, Russia, and Peru are the 5 most severely affected nations. The discovery of the genotype and phenotype of SARS-CoV-2 boosted the global efforts for the development of treatment options and vaccines for the COVID-19. As the transmission of the virus is rapid, to protect the global population, the development of an effective vaccine against the virus is very essential. The current review highlights the various platforms and technologies used globally for the development of the vaccine and also focuses on the current status of the vaccine candidates under development by organizations to combat the global threat of COVID-19 pandemic. SN - 1532-2513 UR - https://www.unboundmedicine.com/medline/citation/33054486/Deciphering_Vaccines_for_COVID_19:_where_do_we_stand_today L2 - https://www.tandfonline.com/doi/full/10.1080/08923973.2020.1837867 DB - PRIME DP - Unbound Medicine ER -